News
Dr. Jim Omel, who was diagnosed with multiple myeloma in 1997, explained how the treatment landscape has changed over nearly ...
Dr. Jacob Sands explained that he believes patients should be having more personalized, nuanced conversations with their ...
Breast cancer survivor and researcher LaShae Rolle studies how individualized strength training during chemo boosts physical, ...
There are many reliable resources available to patients with kidney cancer, as well as their families and caregivers.
Living with stage 4 cancer taught me the power of community; connecting with others provides guidance, support, and hope in ...
Real-world data show that Enhertu benefits those with HR+ breast cancer, whereas Trodelvy is effective as an initial treatment for HER2-null/HER2– disease.
More than half of patients with low platelets treated with Vonjo had a platelet response, with median platelets rising 58% and hemoglobin increasing.
A diverticulitis concern led to a prostate cancer diagnosis that shifted a patient's mindset and highlighted the importance ...
About one in six men with grade group 1 prostate cancer have higher-risk disease, showing outcomes vary and biopsy grade may ...
Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.
Follicular lymphoma survivor Troy Anderson credited acupuncture and nutrition guidance with easing treatment side effects and ...
Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results